XSNXNOVACCESS GLOBAL INC.

About NOVACCESS GLOBAL INC. (XSNX)

NOVACCESS GLOBAL INC. (XSNX) is a Biotechnology company headquartered in Chagrin Falls, OH, United States whose shares trade over-the-counter on the Expert Market tier.

NovAccess Global Inc. is a biopharmaceutical company focused on the development and commercialization of novel immunotherapies to treat brain tumor patients in the United States with plans to expand globally. We are experts in cutting-edge research involving the use of a patient's own immune system to fight cancer. Through our advisory board we have experience successfully executing clinical trials, bringing products to market and increasing the market size of products. Our scientists are well versed in immunology, stem cell biology, neuroscience, molecular biology, imaging, small molecule development and gene therapy as well as other technical assays required for protein and genetic analysis of cancer cells. NovAccess Global is a research and development (R&D) company based in Ohio and California, and our executive management and scientific advisory board have over 15 years of experience in all aspects of biopharmaceutical R&D and commercialization of drug candidates.

Products and services

NovAccess Global Inc. is a biopharmaceutical company that is developing novel immunotherapies to treat brain tumor patients in the United States and eventually Globally.

XSNX key facts

Ticker symbol

XSNX

Market tier

Expert Market

Sector

Healthcare

Industry

Biotechnology

Headquarters

Chagrin Falls, OH, United States

Country of incorporation

US

Year of incorporation

1997

Employees

2

Estimated market cap

$18.5K (as of Apr 15, 2025)

Shares outstanding

61,652,385

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

9/30

Latest filing

8K Report (Jul 26, 2024)

NOVACCESS GLOBAL INC. leadership

• Dwain Irvin — CEO
• Dawn Frazer — Other

Explore more: Biotechnology stocks · Healthcare sector · Expert Market stocks · OTC stocks starting with X